AIG
MDGL icon

American International Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

American International Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Hold
0
– -$25 – 5034
2014
Q2 		– Hold
0
– – – 4946
2014
Q1 		– Hold
0
– – – 4806

Other funds holding MDGL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American International Group's MDGL Position: Q2 2024 in Review

American International Group sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2024, closing a stake of 7,292 shares — an estimated $1.95M sold.

American International Group first reported a position in MDGL in Q2 2013 and held it in 40 quarters. The position peaked at $1.95M in Q1 2024. 257 funds tracked by Wall St. Rank hold MDGL as of Q2 2024.

  • American International Group reported no remaining Madrigal Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 7,292 Madrigal Pharmaceuticals shares in Q2 2024, an estimated $1.95M.
  • American International Group first reported a position in Madrigal Pharmaceuticals in Q2 2013 and held it in 40 quarters.
  • American International Group's Madrigal Pharmaceuticals position peaked at $1.95M in Q1 2024.
  • 257 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.